By Dietrich Knauth

NEW YORK (Reuters) – A Johnson & Johnson (NYSE:) subsidiary can pursue its third attempt to resolve tens of thousands of lawsuits alleging its talc products caused cancer in a Texas bankruptcy court, a judge ruled on Thursday, allowing the company to avoid a venue that shot down its two previous efforts.